Dr. Alexander Starodub, MD
Claim this profileThe Christ Hospital
Studies Solid Tumors
Studies Tumors
17 reported clinical trials
26 drugs studied
Area of expertise
1Solid Tumors
Stage IV
KRAS positive
HRAS positive
2Tumors
Stage IV
KRAS positive
HRAS positive
Affiliated Hospitals
Clinical Trials Alexander Starodub, MD is currently running
PRJ1-3024
for Cancer
This trial tests a new oral medicine, PRJ1-3024, on patients with advanced solid tumors that have not responded to other treatments. The study aims to find a safe dose and see if the medicine can shrink or stop tumor growth.
Recruiting1 award Phase 1
INKmune
for Prostate Cancer
This is an open-label, phase I/IIa dose escalation and expansion study of INKmune in men with mCRPC. INKmune is administered to patients intravenously over three doses, at least one-week apart. The study will consist of two stages.
Recruiting1 award Phase 1 & 210 criteria
More about Alexander Starodub, MD
Clinical Trial Related2 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Alexander Starodub, MD has experience with
- PD-1 Inhibitor
- LUT014 Gel
- YL-17231
- GRT-C901
- GRT-R902
- Atezolizumab
Breakdown of trials Alexander Starodub, MD has run
Solid Tumors
Tumors
Non-Small Cell Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alexander Starodub, MD specialize in?
Alexander Starodub, MD focuses on Solid Tumors and Tumors. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are KRAS positive.
Is Alexander Starodub, MD currently recruiting for clinical trials?
Yes, Alexander Starodub, MD is currently recruiting for 11 clinical trials in Cincinnati Ohio. If you're interested in participating, you should apply.
Are there any treatments that Alexander Starodub, MD has studied deeply?
Yes, Alexander Starodub, MD has studied treatments such as PD-1 inhibitor, LUT014 Gel, YL-17231.
What is the best way to schedule an appointment with Alexander Starodub, MD?
Apply for one of the trials that Alexander Starodub, MD is conducting.
What is the office address of Alexander Starodub, MD?
The office of Alexander Starodub, MD is located at: The Christ Hospital, Cincinnati, Ohio 45219 United States. This is the address for their practice at the The Christ Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.